Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance

中国防痨杂志 Pub Date : 2021-04-10 DOI:10.3969/J.ISSN.1000-6621.2021.04.005

W. Shu, Qiping Ge, Xue-rui Huang, Li-ping Ma, B. Ji, Yu-hui Chen, Xiao-you Chen, G. Jiang, Li Xie, Bo Li, Shengpan Chen, Sen-lin Chen, Junfang Yan, Lian-ke Shi, Ling Chen, You-lun Li, Xiujuan Xi, Qianqian Liu, Xingyan Yan, Fei Wang, Fuqing Wang, Xiang Wu, Peng Zhang, Xuebing Leng, Wenqiang Cao, Haiquan Zhang, H. Cui, Chengliang Yang, Chao Wu, Juan Li, Hua Li, Yu-xian Sun, Li-jie Zhang, S. Xie, Yu-Jia Ning, X. Tian, J. Du, Lianghao Li, Wei-wei Gao

引用次数: 0

查看原文本刊更多论文

异烟肼耐药与利福平耐药肺结核复治疗效分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国防痨杂志

CiteScore

0.50

自引率

0.00%

发文量

9122

期刊介绍： Chinese Journal of Antituberculosis (Editor-in-Chief: Wang Lixia; ISSN 1000-6621, CN 11-2761/R) is published monthly in Chinese by the Chinese Antituberculosis Association, and is a peer reviewed medical journal for doctors, medical researchers, and health workers in the field of tuberculosis. The journal reports the advances and progress in current tuberculosis sciences and technology.